The Claim
Higher plasma and intraplaque osteoprotegerin (OPG) levels are associated with asymptomatic carotid atherosclerosis, with asymptomatic patients exhibiting a mean plasma OPG concentration of 3.2 ng/mL compared to 2.5 ng/mL in symptomatic patients (p=0.05), indicating that OPG is linked to plaque stability rather than vulnerability.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
People with asymptomatic carotid artery plaque have higher levels of osteoprotegerin in their blood and plaque tissue than those with symptomatic plaque, and this difference is statistically significant.
See the scientific wording
Higher levels of osteoprotegerin (OPG) in plasma and within carotid artery plaques are associated with asymptomatic carotid atherosclerosis, with asymptomatic patients showing 3.2 ng/mL average plasma OPG compared to 2.5 ng/mL in symptomatic patients (p=0.05), suggesting OPG may serve as a biomarker for plaque stability rather than vulnerability.
Specialized cells around blood vessels turn into bone-forming cells when exposed to inflammation and mineral signals, releasing a protein that blocks another protein responsible for breaking down bone. This causes hard, stable bone-like tissue to build up inside the artery plaque instead of soft, fragile material, making the plaque less likely to rupture.
What the research says
1 studyPeople with stable, non-symptomatic clogged arteries have more of a protein called OPG in their blood and inside the plaque than those whose plaques caused strokes. This suggests OPG might help keep plaques from breaking apart.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.